IOVANCE BIOTHERAPEUTICS, INC. Investing Cash Flow
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Investing Cash Flow of -$62.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$74.05M, a 634.97% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $11.39M, a 28.19% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $775.00K, a 96.73% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $17.01M.
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2025 was $47.50M.
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$96.41M.
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$155.24M, a 160.53% decline from fiscal 2022.
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2022 was $256.45M, a 194184.09% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 45 month | Net Cash Provided by (Used in) Investing Activities 48 month | Net Cash Provided by (Used in) Investing Activities 51 month | Net Cash Provided by (Used in) Investing Activities 54 month | Net Cash Provided by (Used in) Investing Activities 57 month | Net Cash Provided by (Used in) Investing Activities 60 month | Net Cash Provided by (Used in) Investing Activities 63 month | Net Cash Provided by (Used in) Investing Activities 66 month | Net Cash Provided by (Used in) Investing Activities 69 month | Net Cash Provided by (Used in) Investing Activities 72 month | Net Cash Provided by (Used in) Investing Activities 78 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$74.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$62.66M 10-Q · filed 2026-08-06 | -$61.88M derived: sum of 3 quarters · filed 2026-08-06 | -$44.87M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2026-03-31 | $11.39M 10-Q · filed 2026-05-07 | $12.17M derived: sum of 2 quarters · filed 2026-05-07 | $29.18M derived: sum of 3 quarters · filed 2026-05-07 | $43.02M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2025-12-31 | $775.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $17.79M derived: sum of 2 quarters · filed 2026-02-24 | $31.63M derived: sum of 3 quarters · filed 2026-08-06 | $47.50M 10-K · filed 2026-02-24 | ||||||||||||
| 2025-09-30 | $17.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $30.85M derived: sum of 2 quarters · filed 2026-08-06 | $46.72M 10-Q · filed 2025-11-06 | $70.40M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2025-06-30 | $13.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $29.71M 10-Q · filed 2026-08-06 | $53.39M derived: sum of 3 quarters · filed 2026-08-06 | $4.58M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2025-03-31 | $15.87M 10-Q · filed 2026-05-07 | $39.54M derived: sum of 2 quarters · filed 2026-05-07 | -$9.26M derived: sum of 3 quarters · filed 2026-05-07 | $30.96M derived: sum of 4 quarters · filed 2026-05-07 | ||||||||||||
| 2024-12-31 | $23.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$25.12M derived: sum of 2 quarters · filed 2026-02-24 | $15.10M derived: sum of 3 quarters · filed 2026-02-24 | -$96.41M 10-K · filed 2026-02-24 | ||||||||||||
| 2024-09-30 | -$48.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$8.58M derived: sum of 2 quarters · filed 2025-11-06 | -$120.09M 10-Q · filed 2025-11-06 | -$192.93M derived: sum of 4 quarters · filed 2026-02-24 | ||||||||||||
| 2024-06-30 | $40.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$71.29M 10-Q · filed 2025-08-07 | -$144.13M derived: sum of 3 quarters · filed 2026-02-24 | -$223.15M derived: sum of 4 quarters · filed 2026-02-24 | ||||||||||||
| 2024-03-31 | -$111.51M 10-Q · filed 2025-05-08 | -$184.35M derived: sum of 2 quarters · filed 2026-02-24 | -$263.37M derived: sum of 3 quarters · filed 2026-02-24 | -$420.14M derived: sum of 4 quarters · filed 2026-02-24 | ||||||||||||
| 2023-12-31 | -$72.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$151.86M derived: sum of 2 quarters · filed 2026-02-24 | -$308.64M derived: sum of 3 quarters · filed 2026-02-24 | -$155.24M 10-K · filed 2026-02-24 | ||||||||||||
| 2023-09-30 | -$79.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$235.79M derived: sum of 2 quarters · filed 2024-11-07 | -$82.40M 10-Q · filed 2024-11-07 | -$81.94M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2023-06-30 | -$156.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$3.38M 10-Q · filed 2024-08-08 | -$2.92M derived: sum of 3 quarters · filed 2025-02-27 | $70.79M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2023-03-31 | $153.40M 10-Q · filed 2024-05-09 | $153.86M derived: sum of 2 quarters · filed 2025-02-27 | $227.57M derived: sum of 3 quarters · filed 2025-02-27 | $323.33M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2022-12-31 | $461.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $74.18M derived: sum of 2 quarters · filed 2025-02-27 | $169.94M derived: sum of 3 quarters · filed 2025-02-27 | $256.45M 10-K · filed 2025-02-27 | ||||||||||||
| 2022-09-30 | $73.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $169.48M derived: sum of 2 quarters · filed 2023-11-07 | $255.99M 10-Q · filed 2023-11-07 | $325.33M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2022-06-30 | $95.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $182.28M 10-Q · filed 2023-08-08 | $251.62M derived: sum of 3 quarters · filed 2024-02-28 | $264.37M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2022-03-31 | $86.52M 10-Q · filed 2023-05-10 | $155.85M derived: sum of 2 quarters · filed 2024-02-28 | $168.60M derived: sum of 3 quarters · filed 2024-02-28 | $9.44M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2021-12-31 | $69.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $82.09M derived: sum of 2 quarters · filed 2024-02-28 | -$77.08M derived: sum of 3 quarters · filed 2024-02-28 | $132.00K 10-K · filed 2024-02-28 | ||||||||||||
| 2021-09-30 | $12.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$146.42M derived: sum of 2 quarters · filed 2022-11-03 | -$69.21M 10-Q · filed 2022-11-03 | -$10.45M derived: sum of 4 quarters · filed 2023-02-28 | ||||||||||||
| 2021-06-30 | -$159.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$81.95M 10-Q · filed 2022-08-04 | -$23.20M derived: sum of 3 quarters · filed 2023-02-28 | -$76.16M derived: sum of 4 quarters · filed 2023-02-28 | ||||||||||||
| 2021-03-31 | $77.21M 10-Q · filed 2022-05-05 | $135.96M derived: sum of 2 quarters · filed 2023-02-28 | $83.01M derived: sum of 3 quarters · filed 2023-02-28 | -$340.75M derived: sum of 4 quarters · filed 2023-02-28 | ||||||||||||
| 2020-12-31 | $58.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $5.80M derived: sum of 2 quarters · filed 2023-02-28 | -$417.96M derived: sum of 3 quarters · filed 2023-02-28 | -$317.85M 10-K · filed 2023-02-28 | ||||||||||||
| 2020-09-30 | -$52.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$476.71M derived: sum of 2 quarters · filed 2021-11-04 | -$376.61M 10-Q · filed 2021-11-04 | -$349.79M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||
| 2020-06-30 | -$423.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$323.65M 10-Q · filed 2021-08-05 | -$296.84M derived: sum of 3 quarters · filed 2022-02-24 | -$293.34M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||
| 2020-03-31 | $100.11M 10-Q · filed 2021-05-06 | $126.92M derived: sum of 2 quarters · filed 2022-02-24 | $130.41M derived: sum of 3 quarters · filed 2022-02-24 | $189.10M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||
| 2019-12-31 | $26.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $30.31M derived: sum of 2 quarters · filed 2022-02-24 | $88.99M derived: sum of 3 quarters · filed 2022-02-24 | $90.03M 10-K · filed 2022-02-24 | ||||||||||||
| 2019-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $62.18M derived: sum of 2 quarters · filed 2020-11-05 | $63.21M 10-Q · filed 2020-11-05 | -$143.17M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||
| 2019-06-30 | $58.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $59.72M 10-Q · filed 2020-08-06 | -$146.67M derived: sum of 3 quarters · filed 2021-02-25 | -$296.04M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||
| 2019-03-31 | $1.03M 10-Q · filed 2020-05-05 | -$205.35M derived: sum of 2 quarters · filed 2021-02-25 | -$354.72M derived: sum of 3 quarters · filed 2021-02-25 | -$385.22M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||
| 2018-12-31 | -$206.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$355.75M derived: sum of 2 quarters · filed 2021-02-25 | -$386.26M derived: sum of 3 quarters · filed 2021-02-25 | -$386.28M 10-K · filed 2021-02-25 | ||||||||||||
| 2018-09-30 | -$149.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$179.88M derived: sum of 2 quarters · filed 2019-11-04 | -$179.90M 10-Q · filed 2019-11-04 | -$179.84M derived: sum of 4 quarters · filed 2020-02-25 | ||||||||||||
| 2018-06-30 | -$30.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$30.52M 10-Q · filed 2019-08-01 | -$30.47M derived: sum of 3 quarters · filed 2020-02-25 | -$15.98M derived: sum of 4 quarters · filed 2020-02-25 | ||||||||||||
| 2018-03-31 | -$22.00K 10-Q · filed 2019-05-07 | $36.00K derived: sum of 2 quarters · filed 2020-02-25 | $14.52M derived: sum of 3 quarters · filed 2020-02-25 | $39.85M derived: sum of 4 quarters · filed 2020-02-25 | ||||||||||||
| 2017-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $14.54M derived: sum of 2 quarters · filed 2020-02-25 | $39.88M derived: sum of 3 quarters · filed 2020-02-25 | $58.68M 10-K · filed 2020-02-25 | ||||||||||||
| 2017-09-30 | $14.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $39.82M derived: sum of 2 quarters · filed 2018-11-06 | $58.62M 10-Q · filed 2018-11-06 | $84.38M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||
| 2017-06-30 | $25.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $44.13M 10-Q · filed 2018-08-07 | $69.90M derived: sum of 3 quarters · filed 2019-02-28 | |||||||||||||
| 2017-03-31 | $18.80M 10-Q · filed 2018-05-10 | $44.57M derived: sum of 2 quarters · filed 2019-02-28 | ||||||||||||||
| 2016-12-31 | $25.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $8.89M 10-K · filed 2019-02-28 | ||||||||||||||
| 2016-09-30 | -$16.87M 10-Q · filed 2017-11-02 | |||||||||||||||
| 2015-12-31 | -$71.21M 10-K · filed 2018-03-12 | |||||||||||||||
| 2014-09-30 | -$160.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$162.58K derived: sum of 2 quarters · filed 2014-11-13 | -$166.01K 10-Q · filed 2014-11-13 | -$166.01K derived: sum of 4 quarters · filed 2014-11-13 | ||||||||||||
| 2014-06-30 | -$2.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$5.74K 10-Q · filed 2014-08-08 | -$5.74K derived: sum of 3 quarters · filed 2014-08-08 | -$18.45K derived: sum of 4 quarters · filed 2014-11-13 | ||||||||||||
| 2014-03-31 | -$3.44K 10-Q · filed 2014-05-14 | -$3.44K derived: sum of 2 quarters · filed 2014-05-14 | -$16.14K derived: sum of 3 quarters · filed 2014-11-13 | -$16.14K derived: sum of 4 quarters · filed 2014-11-13 | -$101.19K 10-Q · filed 2014-05-14 | |||||||||||
| 2013-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | -$12.71K derived: sum of 2 quarters · filed 2014-11-13 | -$12.71K derived: sum of 3 quarters · filed 2014-11-13 | -$12.71K 10-K · filed 2014-03-28 | -$97.76K 10-K · filed 2014-03-28 | |||||||||||
| 2013-09-30 | -$12.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$12.70K derived: sum of 2 quarters · filed 2014-11-13 | -$12.70K 10-Q · filed 2014-11-13 | -$12.70K derived: sum of 4 quarters · filed 2014-11-13 | -$97.76K 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $0.00 10-Q · filed 2014-08-08 | $0.00 derived: sum of 3 quarters · filed 2014-08-08 | $0.00 derived: sum of 4 quarters · filed 2014-08-08 | -$85.05K 10-Q · filed 2013-10-23 | |||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-10-23 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | $0.00 derived: sum of 3 quarters · filed 2014-03-28 | $0.00 derived: sum of 4 quarters · filed 2014-03-28 | -$85.05K 10-Q · filed 2013-10-23 | |||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | $0.00 derived: sum of 3 quarters · filed 2014-03-28 | $0.00 10-K · filed 2014-03-28 | -$85.05K 10-K · filed 2013-09-23 | |||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 60 month − 10-Q/A 57 month · filed 2013-01-25 | $0.00 derived: sum of 2 quarters · filed 2013-01-25 | $0.00 10-Q · filed 2013-01-25 | -$60.74K derived: sum of 4 quarters · filed 2013-10-23 | -$85.05K 10-Q · filed 2013-01-25 | |||||||||||
| 2012-06-30 | $0.00 derived: 10-Q/A 57 month − 10-Q 54 month · filed 2012-09-10 | $0.00 derived: sum of 2 quarters · filed 2013-10-23 | -$60.74K derived: sum of 3 quarters · filed 2013-10-23 | -$14.19K derived: sum of 4 quarters · filed 2013-10-23 | -$85.05K 10-Q/A · filed 2012-09-10 | |||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-10-23 | -$60.74K derived: sum of 2 quarters · filed 2013-10-23 | -$14.19K derived: sum of 3 quarters · filed 2013-10-23 | -$31.05K derived: sum of 4 quarters · filed 2013-10-23 | -$85.05K 10-Q · filed 2012-05-15 | |||||||||||
| 2011-12-31 | -$60.74K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23 | -$14.19K derived: sum of 2 quarters · filed 2013-09-23 | -$31.05K derived: sum of 3 quarters · filed 2013-09-23 | -$81.05K 10-K · filed 2013-09-23 | -$85.05K 10-K · filed 2012-03-30 | |||||||||||
| 2011-09-30 | $46.55K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-25 | $29.68K derived: sum of 2 quarters · filed 2013-01-25 | -$20.32K 10-Q · filed 2013-01-25 | -$17.34K derived: sum of 4 quarters · filed 2013-01-25 | -$24.32K 10-Q · filed 2011-11-21 | |||||||||||
| 2011-06-30 | -$16.86K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-10 | -$66.86K 10-Q/A · filed 2012-09-10 | -$16.86K 10-Q/A · filed 2011-09-01 | -$63.88K derived: sum of 3 quarters · filed 2012-09-10 | -$63.88K derived: sum of 4 quarters · filed 2012-09-10 | -$20.86K 10-Q/A · filed 2011-09-01 | ||||||||||
| 2011-03-31 | -$50.00K 10-Q · filed 2012-05-15 | -$47.02K derived: sum of 2 quarters · filed 2012-05-15 | -$47.02K derived: sum of 3 quarters · filed 2012-05-15 | |||||||||||||
| 2010-12-31 | $2.98K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $2.98K derived: sum of 2 quarters · filed 2012-03-30 | $0.00 10-K · filed 2012-03-30 | |||||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | -$2.98K 10-Q · filed 2011-11-21 | ||||||||||||||
| 2010-06-30 | -$2.98K 10-Q/A · filed 2011-09-01 | |||||||||||||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |